全文获取类型
收费全文 | 2860篇 |
免费 | 250篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 7篇 |
儿科学 | 96篇 |
妇产科学 | 46篇 |
基础医学 | 482篇 |
口腔科学 | 24篇 |
临床医学 | 272篇 |
内科学 | 734篇 |
皮肤病学 | 35篇 |
神经病学 | 208篇 |
特种医学 | 109篇 |
外国民族医学 | 1篇 |
外科学 | 340篇 |
综合类 | 142篇 |
一般理论 | 6篇 |
预防医学 | 221篇 |
眼科学 | 27篇 |
药学 | 171篇 |
中国医学 | 17篇 |
肿瘤学 | 194篇 |
出版年
2023年 | 12篇 |
2022年 | 26篇 |
2021年 | 63篇 |
2020年 | 33篇 |
2019年 | 60篇 |
2018年 | 60篇 |
2017年 | 48篇 |
2016年 | 44篇 |
2015年 | 61篇 |
2014年 | 67篇 |
2013年 | 107篇 |
2012年 | 174篇 |
2011年 | 199篇 |
2010年 | 122篇 |
2009年 | 112篇 |
2008年 | 133篇 |
2007年 | 165篇 |
2006年 | 141篇 |
2005年 | 119篇 |
2004年 | 132篇 |
2003年 | 108篇 |
2002年 | 98篇 |
2001年 | 94篇 |
2000年 | 104篇 |
1999年 | 75篇 |
1998年 | 69篇 |
1997年 | 55篇 |
1996年 | 54篇 |
1995年 | 24篇 |
1994年 | 36篇 |
1993年 | 37篇 |
1992年 | 55篇 |
1991年 | 45篇 |
1990年 | 46篇 |
1989年 | 38篇 |
1988年 | 46篇 |
1987年 | 28篇 |
1986年 | 28篇 |
1985年 | 34篇 |
1984年 | 22篇 |
1983年 | 21篇 |
1982年 | 16篇 |
1981年 | 10篇 |
1980年 | 17篇 |
1979年 | 16篇 |
1978年 | 13篇 |
1977年 | 9篇 |
1976年 | 13篇 |
1975年 | 8篇 |
1974年 | 8篇 |
排序方式: 共有3132条查询结果,搜索用时 734 毫秒
71.
Mak Lung-Yi Huang Qi Wong Danny Ka-Ho Stamm Luisa Cheung Ka-Shing Ko Kwan-Lung Yan Ran Ouyang Lea Fung James Seto Wai-Kay Yuen Man-Fung 《Journal of gastroenterology》2021,56(5):479-488
Journal of Gastroenterology - We aimed to assess whether residual hepatitis B virus (HBV) viraemia is associated with HCC development. This is a case–control study of 104 patients [52 HCC and... 相似文献
72.
BACKGROUND: Multiple reports have described associations between occupational inhalant exposure and lung disease. Previous occupational lung disease investigations have studied populations consisting of both smokers and nonsmokers. Smoking complicates interpretation of toxicant exposure-response relationships. The objective of this study was to determine whether, among never-smokers, occupational exposure to gases, dusts, or fumes is associated with a history of respiratory disorders and pulmonary function test defined obstructive lung disease. METHODS: We performed a retrospective analysis of 517 never-smoker patients who underwent pulmonary function testing in our clinical laboratory between 1986 and 1999. We calculated the relative risks of developing adverse respiratory health outcomes given a history of exposure to occupational inhalants. RESULTS: Compared with persons with a negative occupational exposure history, exposed persons had an increased risk of reporting a history of bronchitis [relative risk (RR), 1.59; 95% confidence interval (CI), 1.20-2.12], recurrent lung infections (RR, 2.09; 95% CI, 1.14-3.82), and bronchodilator use (RR, 1.61; 95% CI, 1.26-2.06). There was also a statistically significant association between a history of inhalant exposure and the finding of an obstructive ventilatory defect on pulmonary function testing (RR, 1.79; 95% CI, 1.12-2.85). A history of inhalant exposure was not associated with self-reported asthma (RR, 1.08; 95% CI, 0.83-1.41). The population attributable risk estimates for respiratory disorders due to inhalant exposure were: bronchitis, 23.6%; recurrent lung infection, 36.3%; bronchodilator use, 24.3%; and obstructive lung disease, 29.6%. CONCLUSIONS: Occupational inhalant exposure is a strong risk factor for lung disease in this population of never smokers. A significant burden of respiratory disease in this population may be attributable to occupational inhalant exposure. 相似文献
73.
Mak KH Chan CN Neoh KH Damras T Koh TH Tan HC Lim TT Lau KW Lim YT Lim YL 《The Journal of invasive cardiology》2002,14(5):239-242
The Terumo stent is a new, balloon-expandable, stainless-steel device with a unique multicellular design to provide robust radial force and end-stoppers to prevent dislodgement. We evaluated the early and late clinical and angiographic outcomes of Terumo coronary stent implantation in native coronary arteries using an open, nonrandomized 3-center registry. From July 1998 to June 1999, a total of 118 Terumo stents were implanted in 105 patients (mean age, 58 +/- 10 years). A significant proportion of patients suffered from diabetes (34%), prior myocardial infarction (MI; 43%) and unstable angina (31%). Most target lesions (48%) had unfavorable morphological characteristics (type B2 or C); mean reference luminal diameter was 2.76 +/- 0.41 mm and lesion length was 11.4 +/- 5.3 mm. Primary success in stent deployment was achieved in 103 patients (98%). There was 1 patient with acute stent thrombosis in whom 2 overlapping stents were deployed. Following stenting, the minimal luminal diameter increased from 1.04 +/- 0.48 mm to 2.39 +/- 0.33 mm. Six-month angiography was performed in 97 patients (92%), and the binary angiographic restenosis (> or = 50% narrowing) rate was 16%. Late loss index was 0.50 +/- 0.43. By 6 months, two patients (1.9%) died, two patients (1.9%) had Q-wave MI and 9 patients (8.4%) required repeat coronary interventions. Therefore, our study shows that the Terumo stent is potentially safe and efficacious in the treatment of coronary narrowings, even in the presence of unfavorable clinical conditions and complex lesion morphological characteristics. 相似文献
74.
Immunohistochemical Determination of Hepatic Cytochrome P-4502E1 in Formalin-Fixed, Paraffin-Embedded Sections 总被引:1,自引:0,他引:1
P. A. Cohen K. M. Mak A. S. Rosman I. Kessova V. M. Mishin T. Koivisto C. S. Lieber 《Alcoholism, clinical and experimental research》1997,21(6):1057-1062
Cytochrome P-4502E1 (2E1) is inducible by chronic ethanol consumption that results in enhanced activation of anesthetics and commonly used drugs (such as acetaminophen) to hepatotoxins. Therefore, assessment of hepatic 2E1 is needed in prescribing these drugs for the management of alcoholic patients. Currently, measurement of 2E1 requires either immunohistochemistry on frozen sections or Western blot (WB) analysis of homogenized tissue in excess of that needed for pathology. To obtain a more widely applicable method, we developed a procedure to detect 2E1 by immunohistochemistry in formalin-fixed, paraffin-embedded liver biopsies obtained routinely for diagnosis. Data were collected from rats fed ethanol-containing or control liquid diets for 3 weeks. lmmunostaining was performed using anti-human rabbit 2E1 antibody as the primary antibody, and the immunoreaction was detected by the avidin-biotin immunoperoxidase method after treating sections with target unmasking fluid, an antigen retrieval buffer that enhanced the staining of 2E1. In control rats, 2E1 staining was weak and perivenular. After ethanol feeding, it showed a lobular gradient, strongest perivenular and weakest periportal, similar to that seen in frozen sections. The staining intensity was scored as: 0 (no staining) to 3 (strong staining). The zonal staining was scored as follows: 1 = perivenular zonal staining, 2 = midzonal, and 3 = panlobular. With the product of the two scores, a significant difference was found between alcohol-fed and control rats (5.1 ± 0.3 vs. 0.8 ± 0.2, p < 0.001). 2E1 assessments by WB were also significantly different for these rat pairs (68.5 ± 2.1 vs. 7.9 ± 0.8 arbitrary units/mg protein, p < 0.001), with a parallel increase of immunostaining scores and WB measurement of 2E1 content. This immunohistochemical method was then validated in 14 paraffin-embedded percutaneous human liver biopsy samples. In livers of nonalcoholics, 2E1 staining was seen in the perivenular zone only, whereas in samples of alcoholics, the staining was perivenular to midzonal and sometimes periportal. A significant correlation between the zonal staining scores (rs= 0.67, p < 0.005) or intensity ± zonal staining scores (rs= 0.79, p < 0.001) and WB analysis was found. The immunohistochemical assessments of 2E1 expression in formalin-fixed, paraffin-embedded sections from livers of alcoholics was found to correlate with WB analysis, and lobular distribution was consistent with that seen in frozen sections. The proposed method should therefore be useful for the assessment of 2E1 content in paraffin-embedded liver samples, thereby aiding in the management of heavy drinkers. 相似文献
75.
76.
Mak JC Ho SP Leung RY Ho PL Ooi C Tipoe GL Yan C Ip MS Lam WK Tsang KW 《Respiratory medicine》2005,99(10):1223-1228
Bronchiectasis is a chronic inflammatory and infective airway disease characterized by irreversible dilatation of the bronchi and persistent purulent sputum. Transforming growth factor-beta(1) (TGF-beta(1)) has been found to be increased in the lungs or bronchoalveolar lavage fluid of patients with inflammatory lung diseases. However, little is known on the serum TGF-beta(1) levels in patients with bronchiectasis. We aimed to determine the serum TGF-beta(1) concentrations in 95 patients with stable bronchiectasis (63 women; mean+/-sd age, 58.9+/-14.1 years) and 68 control subjects (23 women; 48.9+/-12.8 years) by ELISA, and to correlate with clinical parameters. The serum TGF-beta(1) levels were significantly higher in bronchiectatic patients compared with control subjects (median [range], 1812.5 pg/ml [1226.4-4114.5 pg/ml] vs. 1342.4 pg/ml [940.3-2371.7 pg/ml]; P<0.001). There was, however, no correlation between serum TGF-beta(1) levels with FEV(1) (% predicted), FVC (% predicted), 24h sputum volume, the number of bronchiectatic lung lobes or total white blood cell count (P>0.05). Our findings support previous indications that TGF-beta(1) may contribute to bronchiectatic airway inflammation. Further studies on the potential mechanisms and pathogenesis implications of this elevation should also be pursued in future. 相似文献
77.
78.
79.
80.
Satoshi Inoue Zhenyue Hao Andrew J. Elia David Cescon Lily Zhou Jennifer Silvester Bryan Snow Isaac S. Harris Masato Sasaki Wanda Y. Li Momoe Itsumi Kazuo Yamamoto Takeshi Ueda Carmen Dominguez-Brauer Chiara Gorrini Iok In Christine Chio Jillian Haight Annick You-Ten Susan McCracken Andrew Wakeham Danny Ghazarian Linda J.Z. Penn Gerry Melino Tak W. Mak 《Genes & development》2013,27(10):1101-1114